Dr. Flemming Ornskov has been Chief Executive Officer at Shiresince April 2013, after being appointed Chief Executive OfficerDesignate and a member of Shire’s Board of Directors in January,2013.
Dr. Ornskov brings to Shire extensive international, strategic and operational experience in the pharmaceutical sector, as well as medical expertise as a former pediatric intensive care physician.
Prior to joining Shire, Dr. Ornskov was Chief Marketing Officer and Global Head, Strategic Marketing for General and Specialty Medicine at Bayer from 2010 to 2012. Previous leadership roles included Global President, Pharmaceuticals and OTC at Bausch & Lomb,Inc., Chairman, President and Chief Executive Officer of Life-Cycle Pharma A/S, and President and Chief Executive Officer of Ikaria, Inc.
Earlier in his career Dr. Ornskov served in roles of increasing responsibility at Merck & Co., and Novartis AG following a distinguished period in hospital and academic medicine. He received his MD from the University of Copenhagen, MBA from INSEAD, and Masters of Public Health from Harvard University.